Chinese medicine formula "jian-Pi-Zhi-Dong Decoction" attenuates Tourette syndrome via downregulating the expression of dopamine transporter in mice

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Wang, Dao Han ^a   Li, Wei ^a   Liu, Xiao Fang ^a   Zhang, Jin Ming ^b   Wang, Su Mei ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3,3' IMINODIPROPIONITRILE; CHINESE DRUG; DOPAMINE TRANSPORTER; JIAN PI ZHI DONG; MESSENGER RNA; SODIUM CHLORIDE; TIAPRIDE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOWN REGULATION; DRUG MECHANISM; GILLES DE LA TOURETTE SYNDROME; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 84874522889     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/385685     Document Type: Article

References (33)

1. Bloch M. H., Leckman J. F., Clinical course of Tourette syndrome. Journal of Psychosomatic Research 2009 67 6 497 501 2-s2.0-70449407842 10.1016/j.jpsychores.2009.09.002
2. Robertson M. M., The prevalence and epidemiology of Gilles de la Tourette syndrome-part 1: the epidemiological and prevalence studies. Journal of Psychosomatic Research 2008 65 5 461 472 2-s2.0-53749095172 10.1016/j. jpsychores.2008.03.006
3. Stern J. S., Burza S., Robertson M. M., Gilles de la Tourette's syndrome and its impact in the UK. Postgraduate Medical Journal 2005 81 95 112 119
4. Winter C., Heinz A., Tourette syndrome as a neurotransmitter disorder. Encyclopedia of Neuroscience 2009 New York, NY, USA Springer 1035 1040
5. Wong D. F., Brašić J. R., Singer H. S., Schretlen D. J., Kuwabara H., Zhou Y., Nandi A., Maris M. A., Alexander M., Ye W., Rousset O., Kumar A., Szabo Z., Gjedde A., Grace A. A., Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET. Neuropsychopharmacology 2008 33 6 1239 1251 2-s2.0-42049113400 10.1038/sj.npp.1301528 (Pubitemid 351521728)
6. Wallace T. L., Gudelsky G. A., Vorhees C. V., Methamphetamine-induced neurotoxicity alters locomotor activity, stereotypic behavior, and stimulated dopamine release in the rat. The Journal of Neuroscience 1999 19 20 9141 9148 2-s2.0-0033570327 (Pubitemid 30226734)
7. Zahniser N. R., Sorkin A., Trafficking of dopamine transporters in psychostimulant actions. Seminars in Cell and Developmental Biology 2009 20 4 411 417 2-s2.0-67649252642 10.1016/j.semcdb.2009.01.004
8. Jones S. R., Gainetdinov R. R., Wightman R. M., Caron M. G., Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. The Journal of Neuroscience 1998 18 6 1979 1986 2-s2.0-0032521354 (Pubitemid 28141404)
9. Wu L. Q., Wang S. M., Cui X., Clinical observation of treating Tourette syndrome by combination of Liujunzi Decoction and Xieqing Pill. Journal of Sichuan of Traditional Chinese Medicine 2006 24 10 81 83
10. Diamond B. I., Reyes M. G., Borison R., A new animal model for Tourette syndrome. Advances in Neurology 1982 35 221 225 2-s2.0-0020453442
11. Khan H. A., Alhomida A. S., Arif I. A., Neurovestibular toxicities of acrylonitrile and iminodipropionitrile in rats: a comparative evaluation of putative mechanisms and target sites. Toxicological Sciences 2009 109 1 124 131 2-s2.0-65549161448 10.1093/toxsci/kfp043
12. Zhang J. M., Tian J. H., Guo Z., Automated online preparation of 11C- β -CFT, a dopamine transporter imaging agent. Chinese Journal of Nuclear Medicine 2005 25 3 142 145
13. Stuss D. T., Alexander M. P., Executive functions and the frontal lobes: a conceptual view. Psychological Research 2000 63 3-4 289 298 2-s2.0-0033654039
14. Kates W. R., Frederikse M., Mostofsky S. H., Folley B. S., Cooper K., Mazur-Hopkins P., Kofman O., Singer H. S., Denckla M. B., Pearlson G. D., Kaufmann W. E., MRI parcellation of the frontal lobe in boys with attention deficit hyperactivity disorder or Tourette syndrome. Psychiatry Research-Neuroimaging 2002 116 1-2 63 81 2-s2.0-0037202599 10.1016/S0925- 4927(02)00066-5 (Pubitemid 35333413)
15. Bortolato M., Chen K., Shih J. C., Monoamine oxidase inactivation: from pathophysiology to therapeutics. Advanced Drug Delivery Reviews 2008 60 13-14 1527 1533 2-s2.0-51249118269 10.1016/j.addr.2008.06.002
16. Feigin A., Kurlan R., McDermott M. P., Beach J., Dimitsopulos T., Brower C. A., Chapieski L., Trinidad K., Como P., Jankovic J., A controlled trial of deprenyl in children with Tourette's syndrome and attention deficit hyperactivity disorder. Neurology 1996 46 4 965 968 2-s2.0-9244264394 (Pubitemid 26134635)
17. Duan K., Tang Y., Effects of total alkaloids from Pinellia ternate on learning, memory and oxidative stress in Parkinson's disease rat models. Acta Laboratorium Animalis Scientia Sinica 2012 20 2 49 52
18. Ruan Q., He X. X., Hu Y. Y., Li F., Effects of different components of Ligusticum chuanxiong Hort of ferulic acid and ligustrazine on the nervous system of mice. Chinese Journal of Hospital Pharmacy 2007 27 8 1087 1090
19. Zhang Z. Q., Tian Y. J., Zhang J., Studies on the antioxidative activity of polysaccharides from radix Saposhnikoviae. Journal of Chinese Medicinal Materials 2008 31 2 268 272 2-s2.0-49949120070
20. Yu L., Zhang Y., Ma R., Bao L., Fang J., Yu T., Potent protection of ferulic acid against excitotoxic effects of maternal intragastric administration of monosodium glutamate at a late stage of pregnancy on developing mouse fetal brain. European Neuropsychopharmacology 2006 16 3 170 177 2-s2.0-33644818867 10.1016/j.euroneuro.2005.08.006 (Pubitemid 43358007)
21. Xu D. D., Hoeven R., Rong R., Cho W. C., Rhynchophylline protects cultured rat neurons against methamphetamine cytotoxicity. Evidence-Based Complementary and Alternative Medicine 2012 2012 7 636091 10.1155/2012/636091
22. Peng C., Xie X., Wang L., Guo L., Hu T., Pharmacodynamic action and mechanism of volatile oil from Rhizoma Ligustici Chuanxiong Hort. on treating headache. Phytomedicine 2009 16 1 25 34 2-s2.0-58149336762 10.1016/j.phymed. 2008.10.010
23. Wang Y. H., Liang S., Xu D. S., Lin X., He C. Y., Feng Y., Hong Y. L., Effect and mechanism of senkyunolide I as an anti-migraine compound from Ligusticum chuanxiong. Journal of Pharmacy and Pharmacology 2011 63 2 261 266 2-s2.0-78751522088 10.1111/j.2042-7158.2010.01191.x
24. Cui X., Wei L., Wang S. M., Influence and mechanism of Jianpizhidong Decoction on autonomic activities in mouse model of Tourette's syndrome. Journal of Beijing University of Traditional Chinese Medicine (Clinical Medicine) 2011 18 1 1 4
25. Wei L., Wang S. M., Yue G. X., Effects of Jianpizhidong Decoction on dopamine pathway in striatum of TS model mice. Chinese Journal of Information on Traditional Chinese Medicine 2009 16 12 38 40
26. Berridge K. C., Aldridge J. W., Houchard K. R., Zhuang X., Sequential super-stereotypy of an instinctive fixed action pattern in hyper-dopaminergic mutant mice: a model of obsessive compulsive disorder and Tourette's. BMC Biology 2005 3, article 4 2-s2.0-27544468773 10.1186/1741-7007-3-4 (Pubitemid 41534980)
27. Rivest R., Falardeau P., Di Paolo T., Brain dopamine transporter: gender differences and effect of chronic haloperidol. Brain Research 1995 692 1-2 269 272 2-s2.0-0029027975 10.1016/0006-8993(95)00611-S
28. Ogawa N., Mizukawa K., Haba K., Sato H., Neurotransmitter and receptor alterations in the rat persistent dyskinesia model induced by iminodipropionitrile. European Neurology 1990 30 1 31 40 2-s2.0-0025058029 (Pubitemid 20037895)
29. Eggers C., Rothenberger A., Berghaus U., Clinical and neurobiological findings in children suffering from tic disease following treatment with tiapride. European Archives of Psychiatry and Neurological Sciences 1988 237 4 223 229 2-s2.0-0023936398
30. Bock N., Moll G. H., Wicker M., Pilz J., Rüther E., Banaschewski T., Huether G., Rothenberger A., Early administration of tiapride to young rats without long-lasting changes in the development of the dopaminergic system. Pharmacopsychiatry 2004 37 4 163 167 2-s2.0-3142768422 10.1055/s-2004-827171 (Pubitemid 38916424)
31. Scatton B., Cohen C., Perrault G., Oblin A., Claustre Y., Schoemaker H., Sanger D. J., Rouquier L., Porsolt R., The preclinical pharmacologic profile of tiapride. European Psychiatry 2001 16 supplement 1 29s 34s 2-s2.0-0035109007
32. Roessner V., Plessen K. J., Rothenberger A., European clinical guidelines for Tourette syndrome and other tic disorders-part II: pharmacological treatment. European Child and Adolescent Psychiatry 2011 20 4 173 196
33. Bressan R. A., Jones H. M., Pilowsky L. S., Atypical antipsychotic drugs and tardive dyskinesia: relevance of D 2 receptor affinity. Journal of Psychopharmacology 2004 18 1 124 127 2-s2.0-2442498598 10.1177/0269881104040251 (Pubitemid 38623105)